Position in DYN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$120,632,414
-$10,277,678 QoQ
Shares Held
6,653,746
-0.6% QoQ
Ownership
4.66%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 11.504466807118877.ToString("F0")%
Shared 0.ToString("F0")%
None 88.49553319288113.ToString("F0")%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,293,122,197 across 420 Biotechnology names. DYN ranks #56 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in DYN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $120,632,414 | 6,653,746 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $130,910,092 | 6,692,745 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $66,651,800 | 5,268,917 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $31,946,054 | 3,355,678 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $37,756,949 | 3,609,651 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $87,581,543 | 3,717,383 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $130,815,575 | 3,641,859 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $112,962,196 | 3,200,969 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $119,054,969 | 4,193,553 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $31,083,975 | 2,337,141 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $17,370,232 | 1,938,642 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $20,022,075 | 1,779,740 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,921,354 | 600,812 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,677,497 | 576,143 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $7,351,776 | 578,880 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $3,845,056 | 559,688 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,829,360 | 500,971 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,854,077 | 492,353 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,872,502 | 484,760 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,655,171 | 458,896 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,531,584 | 227,404 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $4,662,084 | 222,004 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||